Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd A Black

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 24, 2021
The pipeline of new molecules and regimens against drug-resistant tuberculosisTodd A Black, Ulrike K Buchwald
Drug Discovery Today|April 2, 2021
Are outer-membrane targets the solution for MDR Gram-negative bacteria?Scott S Walker, Todd A Black
Nature Reviews. Genetics|May 31, 2003
Genetic strategies for antibacterial drug discoveryLynn Miesel, Jonathan Greene, Todd A Black
DNA Sequence : the Journal of DNA Sequencing and Mapping|September 7, 2004
Analysis of a 108-kb region of the Saccharopolyspora spinosa genome covering the obscurin polyketide synthase locusRoss Zirkle, Todd A Black, Joern Gorlach, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2009
Temporal appearance of plasmid-mediated quinolone resistance genesGeorge A Jacoby, Nancy Gacharna, Todd A Black, et al.
The Journal of Infectious Diseases|April 9, 2010
Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trialPaul McNicholas, Yi Wei, Jeannette Whitcomb, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2011
Mapping and characterization of vicriviroc resistance mutations from HIV-1 isolated from treatment-experienced subjects enrolled in a phase II study (VICTOR-E1)Paul M McNicholas, Paul A Mann, Lisa Wojcik, et al.
Biochimica Et Biophysica Acta|January 25, 2006
Sphingolipid biosynthesis in pathogenic fungi: identification and characterization of the 3-ketosphinganine reductase activity of Candida albicans and Aspergillus fumigatusMichelle Fornarotto, Li Xiao, Yan Hou, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2009
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida speciesPaul A Mann, Paul M McNicholas, Andrew S Chau, et al.
Analytical Biochemistry|December 6, 2005
Escherichia coli acetyl-coenzyme A carboxylase: characterization and development of a high-throughput assayAileen Soriano, Anthony D Radice, Amy H Herbitter, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 24, 2021
The pipeline of new molecules and regimens against drug-resistant tuberculosisTodd A Black, Ulrike K Buchwald
Drug Discovery Today|April 2, 2021
Are outer-membrane targets the solution for MDR Gram-negative bacteria?Scott S Walker, Todd A Black
Nature Reviews. Genetics|May 31, 2003
Genetic strategies for antibacterial drug discoveryLynn Miesel, Jonathan Greene, Todd A Black
DNA Sequence : the Journal of DNA Sequencing and Mapping|September 7, 2004
Analysis of a 108-kb region of the Saccharopolyspora spinosa genome covering the obscurin polyketide synthase locusRoss Zirkle, Todd A Black, Joern Gorlach, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2009
Temporal appearance of plasmid-mediated quinolone resistance genesGeorge A Jacoby, Nancy Gacharna, Todd A Black, et al.
The Journal of Infectious Diseases|April 9, 2010
Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trialPaul McNicholas, Yi Wei, Jeannette Whitcomb, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2011
Mapping and characterization of vicriviroc resistance mutations from HIV-1 isolated from treatment-experienced subjects enrolled in a phase II study (VICTOR-E1)Paul M McNicholas, Paul A Mann, Lisa Wojcik, et al.
Biochimica Et Biophysica Acta|January 25, 2006
Sphingolipid biosynthesis in pathogenic fungi: identification and characterization of the 3-ketosphinganine reductase activity of Candida albicans and Aspergillus fumigatusMichelle Fornarotto, Li Xiao, Yan Hou, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2009
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida speciesPaul A Mann, Paul M McNicholas, Andrew S Chau, et al.
Analytical Biochemistry|December 6, 2005
Escherichia coli acetyl-coenzyme A carboxylase: characterization and development of a high-throughput assayAileen Soriano, Anthony D Radice, Amy H Herbitter, et al.
Pageof 2